Regis Healthcare And 2 Australian Founder Led Growth Stocks

Simply Wall St.11-01 05:23

The recent slump in Wall Street’s previously favoured growth stocks, especially those tied to heavy AI spending, has pushed many investors to rethink where they look for future winners. This is where ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2680082274?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice2-card/1789024931030","is_english":true,"pubTime":"2026-11-01 05:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2680082274","market":"us","top_or_hot":-1,"title":"Regis Healthcare And 2 Australian Founder Led Growth Stocks","media":"Simply Wall St.","content":"<div>\n<p>The recent slump in Wall Street’s previously favoured growth stocks, especially those tied to heavy AI spending, has pushed many investors to rethink where they look for future winners. This is where ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-and-2-australian-founder-led-growth-stocks\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regis Healthcare And 2 Australian Founder Led Growth Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegis Healthcare And 2 Australian Founder Led Growth Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-11-01 05:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-and-2-australian-founder-led-growth-stocks><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent slump in Wall Street’s previously favoured growth stocks, especially those tied to heavy AI spending, has pushed many investors to rethink where they look for future winners. This is where ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-and-2-australian-founder-led-growth-stocks\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4137","symbol_name":"综合支持服务","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-and-2-australian-founder-led-growth-stocks","article_id":"2680082274","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice2-card/1789024931030"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-and-2-australian-founder-led-growth-stocks","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2680082274","pubTimestamp":1793481797,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"The recent slump in Wall Street’s previously favoured growth stocks, especially those tied to heavy AI spending, has pushed many investors to rethink where they look for future winners. This is where fast growing Australian businesses with high insider ownership can be interesting. When founders and executives keep meaningful stakes, their incentives are closely aligned with yours. This article highlights three stocks from that group that may be worth a closer look.\nThe three stocks...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4137":"综合支持服务","QFN.AU":"BetaShares Australian Fincls Sect ETF","XAO.AU":"标普/澳交所 普通股指数","IISV.AU":"INTELL INV SELVAL SHR FD MF","BK7113":"保健护理机构","STW.AU":"SPDR® S&P/ASX 200 ETF","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","GIVE.AU":"PERPETUAL ESG AU SHR EQMF","XJO.AU":"标普/澳交所 200指数","BK4581":"高盛持仓","QRE.AU":"BetaShares Australian Res Sect ETF","BEAR.AU":"BETASHARES AUS EQ BEAR HF","OZF.AU":"SPDR S&P/ASX 200 FINANCIALS","XKO.AU":"标普/澳交所 300指数","XLV":"健康照护类股ETF-SPDR","USD.AU":"BETASHARES US DOLLAR ETF","DACE.AU":"DIMENSIONAL AUST CORE EQ","BK4585":"ETF&股票定投概念","OZR.AU":"SPDR S&P/ASX 200 RESOURCES F","SLF.AU":"SPDR S&P/ASX 200 LISTED PROP","LTR.AU":"LIONTOWN RESOURCES LTD","BK4139":"生物科技","IOZ.AU":"iShares Core S&P/ASX 200","VAP.AU":"VANGUARD AU PROP SEC IDX ETF","EIGA.AU":"EINVEST INCOME GENERATOR FD","BK7095":"多种金属与采矿","ZYAU.AU":"Etfs S&p/asx 300 High Yield Plus Etf","VAS.AU":"VANGUARD AUST SHARES IDX ETF","TLX":"Telix Pharmaceuticals Ltd. (Uplisting)","LABU":"三倍做多标普生物-Direxion","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","TLX.AU":"TELIX PHARMACEUTICALS LTD","HCSG":"Healthcare Svcs Group Inc","USD":"ProShares Ultra Semiconductors","REG.AU":"REGIS HEALTHCARE LTD","XBI":"SPDR S&P Biotech ETF","GEAR.AU":"BETASHARES GEARED AUS EQTY F","E200.AU":"SPDR S&P/ASX 200 ESG FUND","BK7504":"锂钴概念","IMLC.AU":"INV MUTUAL CONC AUS SHAR ETF","BK4588":"碎股","BBOZ.AU":"BETASHARES AUSTRALIAN STRONG BEAR (HEDGE FUND)","IIGF.AU":"Intelligent Investor Australian Equity Growth Fund (Managed Fund)","BK7067":"生物科技"},"translate_title":"Regis Healthcare 和 2 位澳大利亚创始人引领增长股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XBI":0.6,"EIGA.AU":0.6,"VAP.AU":0.6,"ZYAU.AU":0.6,"USD":1,"QFN.AU":0.6,"TLX":0.67,"OZF.AU":0.6,"VAS.AU":0.6,"LABU":0.6,"XJO.AU":1.5,"IMLC.AU":0.6,"GEAR.AU":0.6,"E200.AU":0.6,"OZR.AU":0.6,"QRE.AU":0.6,"USD.AU":1,"STW.AU":0.6,"TLX.AU":1,"SLF.AU":0.6,"REG.AU":1,"LTR.AU":1,"HCSG":1.5,"XKO.AU":1.5,"XLV":1.5,"BBOZ.AU":0.6,"IISV.AU":0.6,"DACE.AU":0.6,"BEAR.AU":0.6,"XAO.AU":1.5,"IOZ.AU":0.6,"GIVE.AU":0.6,"IIGF.AU":0.6},"content_text":"The recent slump in Wall Street’s previously favoured growth stocks, especially those tied to heavy AI spending, has pushed many investors to rethink where they look for future winners. This is where fast growing Australian businesses with high insider ownership can be interesting. When founders and executives keep meaningful stakes, their incentives are closely aligned with yours. This article highlights three stocks from that group that may be worth a closer look. The three stocks highlighted here offer a compelling starting point if you want exposure to fast growing businesses where insiders and external analysts share an optimistic outlook. However, if you want the pick of this theme, these 26 high growth high conviction stocks are the best of the best. AdvertisementRegis Healthcare (ASX:REG) Overview: Regis Healthcare runs residential aged care homes and home care services across Australia, focused on ageing in place and higher acuity support. Operations: Regis Healthcare generates about A$1.35b in revenue from residential aged care, home care and retirement living services entirely within Australia. Market Cap: A$1.45b Regis Healthcare taps directly into the screener’s theme through its expanding network of aged care homes and home care services. Management and analysts both see room for further growth as demand for higher acuity, premium care deepens. \"While higher room pricing and an average incoming RAD close to A$700,000 are already feeding into stronger RAD inflows, the uplift depends on continued demand for premium accommodation and timely IHACPA approvals, which could moderate the pace of revenue and RAD retention driven earnings growth.\"The key variable is how one evolving policy and cost backdrop ultimately feeds through to pricing power and long term margins. That hinges on more than policy settings alone, so read the full narrative for Regis Healthcare to see how pricing, capital needs and resident mix could be decoupling beneath the surface. ASX:REG Revenue & Expenses Breakdown as at Oct 2026 Liontown (ASX:LTR) Overview: Liontown focuses on developing the Kathleen Valley lithium project in Western Australia, with additional exploration exposure to gold and nickel. Operations: Liontown generated A$639 million from exploration and development of mineral projects, with all revenue sourced within Australia. Market Cap: A$2.0b Liontown is connected to the fast growing, insider-backed theme through Kathleen Valley, where management is working to improve lithium recoveries and cost efficiency. \"The company has initiated trials with higher contamination ore, achieving higher lithium recovery rates while maintaining strong recovery even with lower-grade material, which could affect net margins by optimizing processing costs over time.\"What may significantly influence outcomes is how one evolving cost pressure interacts with that recovery work to shape long term profitability. That margin tug of war is only one piece of the story, so read the full narrative for Liontown to see how Liontown’s risk reward profile could be shifting. ASX:LTR Revenue & Expenses Breakdown as at Oct 2026 Telix Pharmaceuticals (ASX:TLX) Overview: Telix Pharmaceuticals develops and commercialises radiopharmaceutical diagnostics and therapies that help doctors find and treat cancers using targeted precision medicine. Operations: Telix generates about US$705 million from Precision Medicine and US$277 million from Manufacturing Solutions, with inter-segment eliminations of US$96 million. Market Cap: A$4.46b Telix Pharmaceuticals fits the fast growing, insider-backed theme through its late stage theranostics pipeline, where TLX591 and companion imaging agents could potentially reshape how major cancers are found and treated if clinical and regulatory milestones line up. \"Their primary revenue generating imaging agents: 'Illuccix' and 'Gozellix', are utilised in 23+ countries worldwide, including key markets such as the U.S, Europe, China and Japan, with revenue figures of $803.8m (USD) in the 2025 Financial Year (within their already upgraded guidance range) provided for FY25, a cash balance of $141.9m (USD), and the potential growth of Gozellix as its launch into the U.S expands.\"What really tests that fast growth story is how one unresolved pressure shapes the balance between funding hungry trials and future pricing power. If that funding trade off matters to you, read the full narrative for Telix Pharmaceuticals to see whether Telix Pharmaceuticals’ current momentum is masking bigger long term swings. ASX:TLX Revenue & Expenses Breakdown as at Oct 2026 Seeking Fresh Alternatives For Your Watchlist New ideas move first. By the time a breakout story hits the front page, early momentum is often gone. Scan these fresh picks before the crowd and act now.  Target reliable cash generators and scan a curated list of solid balance sheet and fundamentals (12 results) before these steadier operators get fully priced by everyone else. Hunt for pricing power and income resilience with a focused pass through 4 dividend fortresses before yields compress and the easy payout opportunities get caught by yield chasers. Ride structural shifts in energy demand by reviewing 16 nuclear energy infrastructure stocks while these potential infrastructure beneficiaries are still under the radar for now.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2680082274","isCrawlerRequest":true}